Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.

Brafman A, Mett I, Shafir M, Gottlieb H, Damari G, Gozlan-Kelner S, Vishnevskia-Dai V, Skaliter R, Einat P, Faerman A, Feinstein E, Shoshani T.

Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3796-805.

PMID:
15452091
2.

The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection.

Simberg D, Weisman S, Talmon Y, Faerman A, Shoshani T, Barenholz Y.

J Biol Chem. 2003 Oct 10;278(41):39858-65. Epub 2003 Jul 17.

3.

Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability.

Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM, Feinstein E.

Oncogene. 2002 Sep 5;21(39):6017-31.

4.

Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E.

Mol Cell Biol. 2002 Apr;22(7):2283-93.

5.

The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.

Chiba-Falek O, Kerem E, Shoshani T, Aviram M, Augarten A, Bentur L, Tal A, Tullis E, Rahat A, Kerem B.

Genomics. 1998 Nov 1;53(3):276-83.

PMID:
9799593
6.
7.

pHaMDR-DHFR bicistronic expression system for mutational analysis of P-glycoprotein.

Zhang S, Sugimoto Y, Shoshani T, Pastan I, Gottesman MM.

Methods Enzymol. 1998;292:474-80. No abstract available.

PMID:
9711575
8.

Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.

Kerem E, Kalman YM, Yahav Y, Shoshani T, Abeliovich D, Szeinberg A, Rivlin J, Blau H, Tal A, Ben-Tur L, et al.

Hum Genet. 1995 Aug;96(2):193-7.

PMID:
7635469
9.

Two novel mutations in the CFTR gene: W1089X in exon 17B and 4010delTATT in exon 21.

Shoshani T, Augarten A, Yahav J, Gazit E, Kerem B.

Hum Mol Genet. 1994 Apr;3(4):657-8. No abstract available.

PMID:
7520798
10.

Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.

Shoshani T, Kerem E, Szeinberg A, Augarten A, Yahav Y, Cohen D, Rivlin J, Tal A, Kerem B.

J Clin Invest. 1994 Apr;93(4):1502-7.

11.

Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.

Sereth H, Shoshani T, Bashan N, Kerem BS.

Hum Genet. 1993 Oct 1;92(3):289-95.

PMID:
7691712
12.

A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews.

Shoshani T, Berkun Y, Yahav Y, Augarten A, Bashan N, Rivlin Y, Gazit E, Sereth H, Kerem E, Kerem BS.

Genomics. 1993 Jan;15(1):236-7. No abstract available.

PMID:
7679367
13.

Cystic fibrosis manifested as undescended testis and absence of vas deferens.

Goshen R, Kerem E, Shoshani T, Kerem BS, Feigin E, Zamir O, Yahav Y.

Pediatrics. 1992 Dec;90(6):982-3. No abstract available.

PMID:
1359500
14.

Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, Tal A, Seret H, Yaar L, Kerem E, et al.

Am J Hum Genet. 1992 Jan;50(1):222-8.

15.
16.
17.

Turnover of purine nucleotides in rabbit erythrocytes. II. Studies in vitro.

Hershko A, Razin A, Shoshani T, Mager J.

Biochim Biophys Acta. 1967 Nov 21;149(1):59-73. No abstract available.

PMID:
5582757
18.

Turnover of purine nucleotides in rabbit erythrocytes. I. Studies in vivo.

Mager J, Hershko A, Zeitlin-Beck R, Shoshani T, Razin A.

Biochim Biophys Acta. 1967 Nov 21;149(1):50-8. No abstract available.

PMID:
5582756

Supplemental Content

Loading ...
Support Center